Cy5.5 NHS Ester (Non-Sulfonated): Empowering Precision Near-Infrared Biomolecule Labeling

Overview: Principle and Setup for Advanced Fluorescent Labeling

In molecular biology and translational research, the demand for sensitive, specific, and deep-tissue compatible fluorescent labeling agents has never been higher. Cy5.5 NHS ester (non-sulfonated) is APExBIO’s flagship near-infrared fluorescent dye for biomolecule labeling, prized for its superior photophysical properties and robust NHS ester chemistry. Operating via N-hydroxysuccinimide (NHS) ester activation, it reacts selectively with primary amines on peptides, proteins, and oligonucleotides, forming stable amide bonds that ensure long-term labeling fidelity.

With an excitation maximum at 684 nm and emission at 710 nm (excitation emission cy5.5), Cy5.5 NHS ester enables deep tissue imaging and in vivo fluorescence imaging with minimized background autofluorescence. Its solubility profile—at least 35.82 mg/mL in DMSO—facilitates high-concentration stock solutions, although it requires dissolution in DMF or DMSO before introduction into aqueous reaction buffers due to low water solubility. This combination of chemical reactivity and optical performance positions Cy5.5 NHS ester (non-sulfonated) as a cornerstone for applications such as tumor imaging agent development, microbiome modulation studies, and fluorescent labeling in molecular biology workflows.

Step-by-Step Experimental Workflow: Maximizing Labeling Efficiency

To unlock the full potential of this near-infrared fluorescent dye for biomolecule labeling, a carefully optimized workflow is essential. Below, we outline a stepwise protocol for labeling proteins or peptides using Cy5.5 NHS ester, incorporating enhancements for yield and reproducibility.

1. Reagent Preparation

• Dissolve Cy5.5 NHS ester: Prepare a fresh stock in anhydrous DMSO or DMF (e.g., 10 mM), immediately before use. Protect from light; avoid repeated freeze-thaw cycles.
• Prepare target biomolecule: Dissolve protein/peptide in a suitable amine-free buffer (e.g., 50 mM sodium bicarbonate, pH 8.3). Avoid Tris or primary amine-containing buffer components that may compete with the conjugation reaction.

2. Conjugation Reaction

• Add Cy5.5 NHS ester slowly to the protein solution at a recommended molar ratio (typically 5–10:1 dye:protein for most applications).
• Incubate at room temperature for 1–2 hours, protected from light. Gentle mixing is recommended.

3. Quenching and Purification

• Quench unreacted NHS ester by adding excess lysine or Tris (if compatible with downstream applications).
• Remove free dye using desalting columns, size-exclusion chromatography, or dialysis.
• Quantify labeling efficiency spectroscopically: measure absorbance at 684 nm (Cy5.5) and at 280 nm (protein) to calculate dye:protein ratio. Typical labeling ranges from 1–5 dye molecules per protein, depending on surface lysine availability.

4. Storage

• Store the labeled conjugate at 4°C, protected from light. For long-term storage, aliquot and freeze at –20°C.

Advanced Applications and Comparative Advantages

Cy5.5 NHS ester (non-sulfonated) has emerged as a go-to amino group labeling reagent and fluorescent dye for protein conjugation in both basic and translational research. Its near-infrared emission enables:

• Optical imaging of tumors: Preclinical studies, such as Kang et al., Sci. Adv. 2025, have leveraged Cy5.5-labeled antibodies and nanovaccines to delineate tumor margins and visualize bacterial populations in vivo. In these experiments, Cy5.5 NHS ester-labeled constructs enabled clear, real-time tracking of tumor-associated bacteria and vaccine distribution within living animal models, outperforming traditional visible-spectrum dyes by providing higher contrast and deeper penetration.
• In vivo fluorescence imaging: Its emission at 710 nm penetrates tissue up to several centimeters, with reported signal-to-background improvements of 5- to 10-fold over Cy3 or FITC analogs (Cy5.5 NHS Ester: Near-Infrared Fluorescent Dye for Advanced Imaging). This makes Cy5.5 NHS ester especially valuable for tracking labeled biomolecules in live animal models, biodistribution studies, and pharmacokinetic analyses.
• Molecular imaging and microbiome modulation: As highlighted in the Reimagining Tumor Imaging and Microbiome Modulation article, Cy5.5 NHS ester’s high labeling efficiency and photostability enable multiplexed imaging of host–microbiome interactions and assessment of microbiome-targeted therapies in complex tissue environments.

Compared to sulfonated Cy5.5 derivatives, this non-sulfonated form exhibits enhanced membrane permeability and compatibility with hydrophobic biomolecules, expanding its utility for labeling nanocarriers, liposomes, and other delivery platforms. The product’s shelf-life (up to 24 months at –20°C, protected from light) and reproducible conjugation chemistry set it apart from less stable or less specific fluorescent probes (Cy5.5 NHS Ester: Non-Sulfonated Near-Infrared Dye for Biomolecule Labeling).

Comparative Highlight: Literature and Workflow Synergy

Three recent articles further contextualize Cy5.5 NHS ester’s unique strengths:

• Next-Generation Tumor Imaging complements this workflow by detailing advanced conjugation strategies for targeted imaging agents, underlining Cy5.5 NHS ester’s versatility in both direct and indirect labeling approaches.
• Illuminating Translational Breakthroughs extends the discussion to neuromodulation and biomimetic nanoplatforms, illustrating how Cy5.5 NHS ester underpins both mechanistic studies and translational pipeline acceleration.
• The aforementioned thought-leadership article contrasts Cy5.5 NHS ester’s performance with traditional dyes, particularly in microbiome-targeted imaging, providing insight into workflow optimization and imaging depth improvements.

Troubleshooting and Optimization Tips

Successful application of Cy5.5 NHS ester (non-sulfonated) depends on careful control of reaction conditions and purification steps. Researchers frequently encounter several recurring challenges:

1. Low Labeling Efficiency

• Check buffer compatibility: Ensure that no competing amines (e.g., Tris, glycine) are present in the reaction buffer.
• pH optimization: Labeling is most efficient at pH 8.3–8.5; lower pH decreases amine reactivity, while higher pH risks protein denaturation.
• Fresh dye preparation: Dissolve Cy5.5 NHS ester immediately before use; avoid prolonged storage in solution.

2. Dye Aggregation or Precipitation

• Solvent choice: Always dissolve in anhydrous DMSO or DMF, and add slowly to the aqueous protein solution with gentle mixing.
• Reaction concentration: Avoid high dye concentrations that may exceed solubility limits, especially in aqueous buffers.

3. Excess Free Dye After Purification

• Purification strategy: Use size-exclusion chromatography or multiple rounds of desalting/dialysis to ensure complete removal of unreacted dye.
• Monitor by absorbance: Ensure free dye is below detection at 684 nm in flow-through or filtrate.

4. Loss of Fluorescence Signal

• Light protection: Cy5.5 NHS ester and its conjugates are light-sensitive; minimize light exposure during and after labeling.
• Storage: Store labeled conjugates in the dark at 4°C (short-term) or –20°C (long-term) to preserve fluorescence intensity.

For new users or high-throughput workflows, consider running small-scale pilot reactions to empirically optimize dye:protein ratios, buffer conditions, and purification steps.

Future Outlook: Expanding the Impact of Cy5.5 NHS Ester in Life Sciences

As research in cancer biology, microbiome modulation, and molecular imaging advances, the role of near-infrared fluorescent dye for biomolecule labeling such as Cy5.5 NHS ester (non-sulfonated) will only grow. The reference study by Kang et al., 2025 exemplifies how Cy5.5-based probes can be harnessed for tracking tumor-associated bacteria, guiding vaccine distribution, and illuminating tumor margins—paving the way for more precise, personalized interventions in oncology and beyond.

Looking forward, integration with multimodal imaging platforms, the development of next-generation antibody–dye conjugates, and expansion into single-cell and spatial transcriptomics are poised to increase the impact of Cy5.5 NHS ester. Its compatibility with both established and emerging analytical platforms ensures continued relevance for high-sensitivity, high-specificity analyses.

For researchers seeking consistent performance, robust labeling, and translational impact, APExBIO’s Cy5.5 NHS ester (non-sulfonated) delivers an industry-leading solution for in vivo fluorescence imaging, molecular biology, and tumor imaging agent development. Its proven track record, demonstrated in peer-reviewed studies and comparative literature, underpins its reputation as an essential tool for life sciences research in the near-infrared domain.